Utility of Restrata With Split Thickness Skin Graft to Reconstruct the Forearm Donor Site
NCT ID: NCT04829331
Last Updated: 2023-04-18
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
5 participants
INTERVENTIONAL
2021-04-09
2022-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Use of Integra in Coverage of Radial Forearm Free Flap Donor Site Defect
NCT02980601
Donor Site Healing Response to Low Level Laser Therapy Following Skin Graft Surgery
NCT05907915
Deep Fascial Graft Versus Acellular Dermal Matrix Conduit on Repaired Hand's Flexor Tendon: A Comparative Study
NCT07074223
Autologous Regenerative Technology (ART) For Wound Healing
NCT03368534
Split-Thickness Skin Graft Donor Site Wound Healing Study
NCT00392301
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Restrata with a split-thickness skin graft
Restrata
Restrata is a sterile, single use device intended for use in local management of wounds
Split-thickness skin graft alone
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Restrata
Restrata is a sterile, single use device intended for use in local management of wounds
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Photo documentation of wound bed at two weeks and four weeks must be obtainable either by physician or patient.
Exclusion Criteria
2. Diabetes mellitus with most recent Hemoglobin A1c ≥10.0 within 30 days prior to surgery.
3. Morbid obesity (BMI \>40).
4. Inability to maintain wrist immobilization for full planned period.
5. Severe malnutrition (prealbumin levels \<10 mg per dL within 30 days prior to surgery OR BMI \<15 (very severely underweight).
6. Other conditions felt to significantly impair wound healing per surgeon discretion.
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Acera Surgical, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nebraska Methodist Hospital
Omaha, Nebraska, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-RES-003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.